Patrick W. Morgan
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- COVID-19 Clinical Research Studies 18
- SARS-CoV-2 and COVID-19 Research 4
-
- Cardiac Arrest and Resuscitation 2
- Co-authors
- Andrew Rhodes (1 shared paper)Nawaf Al-Subaie (1 shared paper)Jeffrey Kristan (2 shared papers)Jon C. Rittenberger (2 shared papers)Clifton W. Callaway (2 shared papers)Jonathan Elmer (1 shared paper)Michael J. Lynch (1 shared paper)Allison C Koller (1 shared paper)
- Journals
- The Lancet (7 papers)The Lancet Respiratory Medicine (3 papers)Resuscitation (2 papers)Open Forum Infectious Diseases (2 papers)Science Immunology (1 paper)
- Partner nations
- United KingdomUnited StatesNepal
In The Last Decade
Patrick W. Morgan
32 papers receiving 4.4k citations
Patrick W. Morgan's Hit Papers
Peers
Comparison fields: 5 of 122
- Infectious Diseases 3.1k
- Applied Microbiology and Biotechnology 112
- Neurology 221
- Genetics 337
- Modeling and Simulation 48
Countries citing papers authored by Patrick W. Morgan
This map shows the geographic impact of Patrick W. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick W. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick W. Morgan more than expected).
Fields of papers citing papers by Patrick W. Morgan
This network shows the impact of papers produced by Patrick W. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick W. Morgan. The network helps show where Patrick W. Morgan may publish in the future.
Co-authors
The 8 scholars most cited alongside Patrick W. Morgan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses Hit paper breakdown → | 2022 | 746 |
| 2 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 3 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 4 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 5 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 6 | 2021 | 256 | |
| 7 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 8 | 2021 | 213 | |
| 9 | 2021 | 172 | |
| 10 | 2021 | 161 | |
| 11 | 2021 | 138 | |
| 12 | 2021 | 121 | |
| 13 | 2022 | 87 | |
| 14 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 15 | 2021 | 81 | |
| 16 | 2021 | 70 | |
| 17 | 2021 | 68 | |
| 18 | Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease Hit paper breakdown → | 2024 | 65 |
| 19 | 2021 | 51 | |
| 20 | 2008 | 39 |
About Patrick W. Morgan
Patrick W. Morgan is a scholar working on Infectious Diseases, Emergency Medicine, Epidemiology, Neurology and Geriatrics and Gerontology, having authored 32 papers that have together received 4.6k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (18 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Sepsis Diagnosis and Treatment (3 papers), Cardiac Arrest and Resuscitation (2 papers), Long-Term Effects of COVID-19 (2 papers), Dementia and Cognitive Impairment Research (1 paper), Acute Kidney Injury Research (1 paper) and Respiratory viral infections research (1 paper). The work is most often cited by research in Infectious Diseases (3.1k citations), Applied Microbiology and Biotechnology (112 citations), Neurology (221 citations), Genetics (337 citations) and Modeling and Simulation (48 citations). Patrick W. Morgan has collaborated with scholars based in United Kingdom, United States and Nepal. Frequent co-authors include Andrew Rhodes, Nawaf Al-Subaie, Jeffrey Kristan, Jon C. Rittenberger, Clifton W. Callaway, Jonathan Elmer, Michael J. Lynch and Allison C Koller. Their work appears in journals such as The Lancet, The Lancet Respiratory Medicine, Resuscitation, Open Forum Infectious Diseases and Science Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.